Choose your region

Don't see your region/country
listed? Visit our global website

SEC filing details

Document Details

Form
Filing Date
Sep 10, 2026
Document Date
Sep 8, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Vertex Pharmaceuticals
Issuer
VERTEX PHARMACEUTICALS INC / MA
Filer
VAN GRUNSVEN JASPER